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B4.6 Management Algorithm for Intermittent Claudication
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B 4.6.2 Complete Management Algorithm for Intermittent Claudication
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B5 Economic Aspects of Intermittent Claudication
Cost data on the diagnosis or treatment of claudication appear to be very scarce in the medical
and the economic literature. This is partly because analyses of claudicants have presented results
on the global cost of tile disease (including all types of patients) or instead of the Fontaine clas-
sification have used some other grouping method that renders interpretation of the results diffi-
cult. In other cases, the results concerned small numbers of patients with minimal description of
the sampling methods and little external validity. In the results presented later in this document
and also in Economic Aspects of Acute Limb Ischemia and Economic Aspects of Critical Limb
Ischemia, costs are in US dollars with the European Euro in brackets, and local currencies were
converted based on tile Organisation for Economic Cooperation and Development (OECD)
purchasing power parity index. The year of the study is indicated.
B 5.1.1 Diagnostic Strategies
When assessing diagnostic strategies for patients with claudication, tile economic analysis can
focus on (1) tile most effective diagnostic strategy for a given individual, (2) the screening
strategy for the population at large, or (3) a subset of those presenting risk factors (eg, smoking
or cardiac disease). The investigations concern risk factors that could benefit from secondary
prevention-diseased peripheral arteries and the circulatory system (heart, brain)-to ascertain a
diagnosis, but more significantly, to plan tile most appropriate treatment, In countries where the
economic constraints have resulted in a limited supply of high-technology facilities, the optimal
use of these facilities is a major issue. Thus, an investigation may be extremely cost-effective if it
